Science & Enterprise subscription

Follow us on Twitter

  • Four pharmaceutical companies are signing on to an initiative that promises to make clinical trials friendlier to p… https://t.co/VNbOdOc8i5
    about 5 hours ago
  • New post on Science and Enterprise: Pharmas Join Digital Clinical Trial Project https://t.co/FkhSAEntxd #Science #Business
    about 5 hours ago
  • A robot device is being developed that can fly through the air and drive along the ground with a single motor, and… https://t.co/hyeUKY5hR0
    about 9 hours ago
  • New post on Science and Enterprise: Flying, Driving Drone Robot Unveiled https://t.co/5aAqW1FhfK #Science #Business
    about 9 hours ago
  • A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear… https://t.co/y4qOmPcuWK
    about 1 day ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Light-Enabled Nanoparticles Detect Early Infection Signs

Tuan Vo-Dinh (Duke University)

Tuan Vo-Dinh (Duke University)

Biomedical and genomic researchers at Duke University in North Carolina developed a technique with light and silver nanoparticles to detect infections earlier than when patients may even report symptoms. The team led by biomedical engineering professor Tuan Vo-Dinh and genomic medicine professor Geoffrey Ginsburg published its findings online in a recent issue of the journal Analytica Chimica Acta (paid subscription required).

The process devised by the Duke team adapts a method of visual energy measurement called surface-enhanced Raman scattering or SERS that detects the light scattered back from the interaction of a light beam with a physical sample. The scattered response, however, is usually weak, requiring an additional enhancement process, which makes it possible to detect scatters from samples as small as a single molecule.

In a proof-of-concept study Vo-Dinh, Ginsburg, and colleagues devised a nanoscale probe they call a molecular sentinel that uses silver nanoparticles with genetic material used in molecular assays. The silver nanoparticles bind to specific molecular biomarkers, in this case, a ribonucleic acid or RNA target for the RSAD2 gene, a biomarker for respiratory infections. Reflections from the target return a unique SERS pattern, providing an optical fingerprint for the biomarker.

Vo-Dinh says the binding of the silver with the biomarker vastly enhances the SERS technique, often by more than a million times. He adds that the tests reported in the paper were the first time these nanoprobes detected specific genetic materials in human samples.

The tests can be designed, say the researchers, to find the infection biomarkers as soon as they enter the blood stream, which may be sooner than the patient even reports symptoms of the infection. While the Duke study tested samples in the lab, the researchers used a portable Raman spectrometer for the tests, which indicates the technology can likely be engineered into point-of-care diagnostics for detecting early signs of infection.

Vo-Dinh, Ginsburg, and colleagues are developing the technique further so it can be placed on a chip device. The researchers say the diagnostic devices could also be designed to test for multiple biomarkers.

Read more:

*     *     *

Please share Science & Enterprise ...
error

Comments are closed.